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Nonpathogenic SIV Infection of Sooty Mangabeys
Is Characterized by Limited Bystander
Immunopathology Despite Chronic High-Level Viremia
HIV infection in humans and SIV infection of rhesus ma-
caques (Macaca mulatta [RMs]).
Despite extensive research efforts, several key issues
regarding the immunopathogenesis of AIDS have yet to
be elucidated. These include the relative pathogenic
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Emory University Influential studies demonstrated that the high viremia
Atlanta, Georgia observed in the pathogenic HIV or SIV infections reflects
continuous rounds of virus infection and the ongoing
destruction of infected cells (Ho et al., 1995; Wei et al.,
Summary 1995; Nowak et al., 1997). These observations led to
formulation of a dynamic model of AIDS wherein active
HIV-infected humans and SIV-infected rhesus macaques HIV replication induces CD4 T cell destruction at such
who remain healthy despite long-term infection exhibit a high rate that host compensatory mechanisms are
exceptionally low levels of virus replication and active eventually overwhelmed. This model places direct, vi-
antiviral cellular immune responses. In contrast, sooty rus-induced CD4 T cell destruction as the central event
mangabey monkeys that represent natural hosts for leading to the numerical and functional collapse of the
SIV infection do not develop AIDS despite high levels
immune system following HIV infection.
of virus replication and limited antiviral CD8 T cell
Although the direct cytopathic potential of HIV is well
responses. We report here that SIV-infected mangabeys
established, indirect mechanisms of T cell depletion
maintain preserved T lymphocyte populations and re-
have also been proposed as significant contributors togenerative capacity and manifest far lower levels of
the development of progressive immunodeficiency thataberrant immune activation and apoptosis than are
follows HIV infection (McCune, 2001; Grossman et al.,seen in pathogenic SIV and HIV infections. These data
2002). Such indirect mechanisms include the loss ofsuggest that direct consequences of virus replication
uninfected T cells due to increased levels of apoptosisalone cannot account for progressive CD4 T cell
and the impairment of lymphoid regenerative capacity.depletion leading to AIDS. Rather, attenuated immune
The apoptotic loss of uninfected T cells involves bothactivation enables SIV-infected mangabeys to avoid
CD4 and CD8 T cells and is thought to be related tothe bystander damage seen in pathogenic infections
the chronic high levels of generalized immune activationand protects them from developing AIDS.
that accompany pathogenic HIV and SIV infections
(Ameisen and Capron, 1991; Meyaard et al., 1992; FinkelIntroduction
et al., 1995; Gougeon et al., 1996). Consistent with this
notion are the observations that the level of CD8 T cellThe AIDS pandemic arose from zoonotic transmission to
activation is as strong a predictor of disease progressionhumans of CD4 lymphocyte-tropic lentiviruses (termed
in HIV-infected individuals as the level of plasma viremiaSimian Immunodeficiency Virus [SIV]) that are prevalent
(Giorgi et al., 1999), and that in both HIV-1 and HIV-2-in particular nonhuman primates. Human Immunodefi-
infections, the extent of CD4 T cell depletion correlatesciency Virus-type 1 (HIV-1) originated from SIVcpz, a
more closely with levels of immune activation than withnatural infection in chimpanzees (Pan troglodytes trog-
viral load (Sousa et al., 2002).lodytes), while HIV-2 originated from SIVsm present in
In addition to the increased death rates of CD4 Tsooty mangabey monkeys ([SMs]; Cercocebus atys)
cells resulting from both direct and indirect mecha-(Hahn et al., 2000). Importantly, the absence of any AIDS-
nisms, others have proposed that CD4 T cell declinerelated disease is a feature common to all known circum-
results primarily from the inability of the infected hoststances of primate lentivirus infection in their natural
to adequately replace CD4 T cells, rather than fromhosts (Hahn et al., 2000; Weiss, 2001). In contrast, trans-
mission of SIVs to nonnatural hosts results in persistent their excessive destruction alone (McCune, 2001). In this
infections associated with progressive loss of CD4 T alternative model, a key factor is the extent to which the
cells and profound susceptibility to opportunistic infec- direct or indirect consequences of HIV infection interfere
tions. This outcome is commonly observed following with effective lymphocyte proliferation necessary to
compensate for the ongoing T cell destruction in the
infected host (Hellerstein et al., 1999; McCune, 2001).*Correspondence: mbf@sph.emory.edu
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Table 1. Age, Age at First Available SIV Test, Levels of SIV Plasma
Viremia (copies/ml of plasma) and CD4 Counts per mm3 in SIV-
Infected and SIV-Uninfected Sooty Mangabeys
Age Age at First
Code (Years) SIV Test Viremia CD4 Count
FCP 6 2 4,479,146 1241
FOO 6 2 534,885 642
FUP 6 2 160,075 1801
FBO 7 2 197,420 819
FDO 7 4 1,961,945 1472
FJO 7 3 366,200 549
FYN 7 3 383,310 472
FEM 8 4 284,645 836
FWK 9 3 3,014,000 859
FFJ 10 5 340,070 315 Figure 1. Lack of Correlation between CD4 T Cell Counts and SIV-
FQJ 10 4 88,410 936 Plasma Viremia in 18 Naturally SIV-Infected SMs
FBI 12 10 987,500 465 Best-fit line is shown.
FRH 12 6 1,279,490 726
FDH 13 5 257,831 1242
FNG 13 4 244,805 631
ResultsFPH 13 9 N.A. 1023
FQG 13 6 642,435 1145
FEF 15 11 777,695 1265 SIV-Infected SMs Remain Healthy Despite
FAC 22 13 107,075 565 Long-Term, High-Level Virus Replication
To characterize the impact of SIV infection on immuneFRV 2 N.A. neg 2584
system composition and function in naturally infectedFCQ 5 N.A. neg 1474
FFR 5 N.A. neg 836 SMs, we performed a cross-sectional comparison of
FRO 6 N.A. neg 678 19 SIV-infected and 10 uninfected SMs (Table 1). SIV-
FSO 6 N.A. neg 618 positive animals were estimated to have been infected
FUO 6 N.A. neg 1620
for 3 to 19 years. All animals studied were healthy andFLN 7 N.A. neg 1237
free of any signs of immune deficiency, opportunisticFZN 7 N.A. neg 1079
infections, neoplasia, wasting syndromes, or neurologi-FYL 8 N.A. neg 1375
FFK 10 N.A. neg 974 cal diseases.
As in HIV-infected humans and SIV-infected RMs,
measurement of levels of viral RNA in the plasma of
infected SMs provides a measure of the levels of ongo-Suppression of bone marrow (BM) and thymic function,
and damage to peripheral lymphoid tissue architecture, ing virus replication in vivo. Due to the known high-
sequence diversity of feral SIVsmm isolates, we devel-are all likely to be important factors contributing to the
ultimate failure of homeostatic mechanisms that main- oped two real-time RT-PCR assays targeting conserved
gag or 5-untranslated region (UTR) sequences to quan-tain lymphocyte populations (Douek et al., 1998; Moses
et al., 1998; Haase, 1999). Overall, these observations titate levels of plasma SIVsmm RNA in naturally infected
SMs (S.I.S. et al., unpublished data). The gag and thesuggest that AIDS is not simply due to viral factors alone,
but rather reflects the outcome of a complex balance UTR-based assay gave similar results; gag PCR results
are reported in this study (Table 1).between the direct impact of virus infection and the host
response to the infection. SIV viral load ranged between 105 and 107 copies of
SIV RNA/ml of plasma (Table 1). These levels are as highTo better understand the mechanism of T cell deple-
tion underlying the immunopathogenesis of AIDS, we or higher than those known to be associated with rapid
progression to AIDS in HIV-infected humans and SIV-have focused our attention on the immunological fea-
tures of nonpathogenic SIV infection in SMs, a natural infected RMs (Mellors et al., 1996; Lifson et al., 1997;
Staprans et al., 1999; Watson et al., 1997). Levels ofhost species for SIV infection. Although SIV infection is
prevalent in SMs living in the wild and in captivity (Fultz plasma viremia in infected animals did not correlate with
age or length of infection. No correlation was foundet al., 1990), progression to AIDS is not observed despite
chronic high levels of viremia (Rey-Cuille et al., 1998; between CD4 T cell counts and viremia levels in SIV-
infected SMs (Figure 1).Chakrabarti et al., 2000). To investigate this apparent
paradox, we performed a cross-sectional phenotypic
and functional analysis of lymphocyte populations in Normal Lymphocyte Immunophenotype and Function
in SIV-Infected SMsSIV-infected and uninfected SMs. In marked contrast to
pathogenic HIV and SIV infections, we found that SIV- HIV infection in humans is characterized by a complex
set of changes in lymphocyte subpopulations, includinginfected SMs display limited immune activation and by-
stander immunopathology and maintain preserved im- progressive diminution of CD4T cell numbers, progres-
sive depletion of naive T cells, increased levels of acti-mune regenerative capacity. These results argue for a
prominent, if not primary, role of the indirect mecha- vated CD8 cells, loss of CD8 T cells expressing the
costimulatory molecule CD28, and increased expres-nisms of lymphocyte depletion in the immuno-
pathogenesis of AIDS. sion of CD95 by both CD4 and CD8 T cells (Choremi-
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Table 2. Hematological and Immunophenotypic Analysis of Peripheral Blood- and Lymph Node-Derived Lymphocytes Isolated from
SIV-Infected and Uninifected Sooty Mangabeys
SIV-Pos (19) SIV-Neg (10)
WBC/cmm 7836 2705 ns 8355  2518
Platelets/cmm 253  88 ns 230  47
Lymphoytes/cmm 4429 1703 ns 4450  1311
CD16% 6.7  4.4 p  0.05 3.7  2.4
CD20% 9.8  5.6 ns 11.6  1.9
CD4/cmm 895  338 ns 1277  602
CD4% 20.2  5.4 p  0.01 28.5  5.3
CD4% (LN) 39.9  14.7 ns 45.6  5.5
CD8/cmm 2151  838 p  0.05 1485  505
CD8% 49.0  11.5 p  0.01 33.7  7.0
CD8% (LN) 19.0  4.4 ns 23.8  4.4
CD4/CD8 0.48  0.27 p  0.01 0.87  0.36
CD4CD25% 7.8  3.6 ns 7.7  3.6
CD4DR% 13.2  9.2 p  0.05 7.7  3.8
CD4CD69% 0.5  0.2 ns 0.4  0.1
CD4CD69% (LN) 18.0  6.3 ns 15.8  3.4
CD4“naive”% 27.0  14.5 ns 26.1  10.3
CD4“naive”/cmm 268  251 ns 359  311
CD8DR% 51.1  12.1 p  0.001 23.4  7.0
CD8DR% (LN) 22.9  9.9 p  0.05 13.1  1.0
CD8CD38% 26.9  10.0 p  0.01 16.5  5.1
CD8CD38% (LN) 5.4  2.0 ns 5.8  3.8
CD8CD28% 33.5  9.9 p  0.001 48.7  10.3
CD8CD28/cmm 717  342 ns 701  217
CD8CD28% (LN) 88.0  7.3 ns 87.0  7.7
CD8CD69% 12.2  7.1 ns 11.4  6.0
CD8“naive”% 19.1  10.2 p  0.05 29.6  11.7
CD8“naive”/cmm 416  295 ns 414  160
3-Thy-incorp. (cpm/106 cells) 102  34 ns 99  23
CD4IL-2 67.7  11.0 ns 72.0  5.5
CD4IL-4 8.4  2.5 p  0.01 5.3  1.3
CD4IL-10 1.04  1.07 ns 0.47  0.62
CD4IFN 20.1  5.3 p  0.01 32.9  11.4
CD4TNF 62.3  17.2 ns 62.5  9.9
CD8IL-2 20.7  8.5 ns 24.7  10.2
CD8IL-4 2.2  1.2 ns 1.2  0.4
CD8IFN 73.9  9.1 ns 67.8  16.4
CD8TNF 59.2  15.0 ns 51.3  12.2
CD95 MFI on CD4 182  59 ns 175  65
CD95 MFI on CD4 (LN) 84.0  7.8 ns 83.0  7.4
CD95 MFI on CD8 173  30 ns 154  38
CD4CD95L 2.44  1.35 ns 2.74  1.70
CD4CD95L 1.57  0.86 ns 2.12  1.38
CD4Apo2.7 0.94  1.64 ns 0.54  0.61
CD8Apo2.7 0.83  0.95 ns 0.60  0.74
CD4Ki67 (PB) 3.12  2.31 p  0.01 1.49  1.13
CD8Ki67 (PB) 1.54  1.73 ns 1.53  1.53
CD4Ki67 (LN) 1.19  0.30 ns 1.08  0.55
CD8Ki67 (LN) 1.28  0.51 ns 1.18  0.61
CD4Ki67 (BM) 10.4  5.01 p  0.01 4.80  1.71
CD8Ki67 (BM) 5.41  2.10 ns 4.45  1.73
Papadopoulou et al., 1994; Roederer et al., 1995; Gehri expansion of the CD8 T cells coexpressing the activa-
tion markers CD38 and HLA-DR (but not CD69) waset al., 1996; Ullum et al., 1997). Immunophenotypic anal-
yses of SIV-infected and uninfected SMs revealed only found in SIV-infected as compared to uninfected SMs.
This expansion of activated CD8 T cells contributes torelatively minor and statistically insignificant decreases
in total CD4 T cell counts in SIV-infected animals (Table significant increases in CD8 T cell percentages and
absolute numbers in SIV-infected SMs (Table 2). As a2). Furthermore, equivalent numbers of naive CD4 and
CD8 T cells (CD45RACD62L) were present in SIV- result of the increased total number of CD8 T cells
found in infected animals, the percentage of CD4 Tinfected and uninfected SMs (Table 2). While SIV-infected
SMs showed no increase in levels of CD4 T cells ex- cells is slightly lower in SIV-infected as compared to
uninfected SMs. In contrast to the CD8T cell lymphocy-pressing the activation markers CD25 or HLA-DR, an
Immunity
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Figure 2. Bone Marrow and Lymph Node Morphology in SIV-Infected and Uninfected SMs
Histological features of a BM biopsy in an SIV-infected SM (HE 40) (A) and an uninfected SM (B). Histological features of an inguinal LN in
an SIV-infected SM (HE staining, 40) (C) and of an uninfected animal (D). In situ detection of apoptotic cells using the TUNEL assay in a LN
section from an SIV-infected SM (E) and an uninfected animal (F).
tosis seen in pathogenic HIV and SIV infections, the contrast to the diminished levels of mitogen-induced
proliferation seen in HIV-infected individuals, lympho-CD8 T cell expansion observed in SIV-infected SMs is
not accompanied by a decrease in the number of naive cytes from SIV-infected SMs showed proliferative re-
sponses equivalent to those of uninfected animals (Ta-CD8 cells or in the number of CD8CD28 T cells.
HIV infection leads to a defect in T cell proliferation ble 2).
Numerous and somewhat contradictory reports haveex vivo, the magnitude of which is predictive of risk for
progression to AIDS (Meyaard et al., 1994). The genesis sought to link HIV infection with specific perturbations in
the balance of lymphocytes that undergo differentiationof this defect is likely to be multifactorial, including en-
hanced susceptibility to apoptosis, anergy, and de- toward either Th1 or Th2 patterns of cytokine production
(Clerici and Shearer, 1993; Graziosi et al., 1994). To in-creased proliferative potential. To investigate potential
differences in the ability of lymphocytes from SIV-infected vestigate if SIV infection of SMs is characterized by a
specific pattern of cytokine production, we used intra-and uninfected SMs to undergo proliferation ex vivo, cells
were activated in culture with ConA, and T cell prolifera- cellular staining to assess the production in both CD4
and CD8 T cells of IL-2, IL-4, IL-10, IFN, and TNF-,tion was quantified via incorporation of 3H-thymidine. In
Nonpathogenic SIV Infection of Sooty Mangabeys
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Figure 3. TREC Levels in Sorted CD4 and
CD8 T Cells from SIV-Infected and Unin-
fected Infected SMs
Isolated CD4 (left panel, 17 animals per group)
and CD8 (right panel, 19 animals per group)
T cells were assessed for TREC levels. TREC
levels are plotted against the age, with best-
fit lines shown (solid line for uninfected,
dashed line for infected SMs).
induced by brief PMA/A23187 treatment ex vivo (Table those of others (Fleury et al., 1998; Sachsenberg et al.,
1998) indicate that CD4 and CD8 T cell populations2). CD4 T cells from SIV-infected animals showed sig-
nificantly increased IL-4 production and significantly may be differentially impacted in both nonpathogenic
and pathogenic lentivirus infections, we performed thedecreased IFN production compared to uninfected ani-
mals. The same trend was also observed when sponta- quantitation of TRECs on purified CD4 and CD8 T
cell subpopulations. As previously reported in humans,neous production of IL-4 and IFN was studied (data
not shown). These results suggest that a preferential TREC levels decrease with age in both uninfected and
SIV-infected SMs (Figure 3). Analysis of SIV-infecteddifferentiation of CD4 T cells toward a Th2 pattern of
cytokine production may follow SIV infection of SMs. SMs revealed that the level of TRECs in the CD4 sorted
subpopulation fits within the range of age-matched un-
infected animals. Finding normal TRECs in CD4 T lym-Preservation of BM Function in SIV-infected SMs
HIV infection of humans and SIV infection of RMs are phocytes from SIV-infected SMs is consistent with the
preservation of the naive CD4 T cell compartment re-commonly associated with progressively severe sup-
pression of BM function, resulting in neutropenia, throm- vealed by flow cytometric analysis. These results indicate
that SIV-infected SMs do not experience the decline inbocytopenia, and total lymphopenia (Moses et al., 1998).
BM suppression may contribute to exhaustion of CD4 TREC levels observed in pathogenic SIV infections of
RMs (Sodora et al., 2002). Interestingly, SIV-infectedT cell regenerative capacity by limiting the production
of prethymic T lymphocyte progenitors, an effect that SMs display a slight but significant decrease in the levels
of TRECs in CD8 T cells when compared to uninfectedis ameliorated by antiretroviral therapy (Huang et al.,
2000). BM aspirates were obtained from 10 SIV-infected animals (p  0.05). This difference remains significant
when analysis of covariance is used to adjust for theand 8 uninfected animals. No signs of aplasia, dysplasia,
hypercellularity, or other BM abnormalities were ob- normal decline in thymic production seen with increas-
ing age. The observed decrease in TRECs in CD8 cellsserved (Figure 2). Absence of measurable BM suppres-
sion is consistent with normal lymphocyte, neutrophil, is inversely correlated with the level of prevailing im-
mune activation in individual SMs as measured by CD38and platelet counts present in the peripheral blood (PB)
of infected as compared with uninfected SMs (Table 2). or DR expression on CD8 cells (p  0.05, data not
shown), likely reflecting an increased number of CD8
T cells with a history of prior proliferation.Preservation of Thymic Function in SIV-Infected SMs
T cell receptor excision circles (TRECs) are episomal
DNA circles that are excised during the rearrangement Preservation of Lymph Node Structure and Function
in SIV-Infected SMsof the T cell receptor genes of maturing T cells within
the thymus (Douek et al., 1998; Zhang et al., 1999). LNs constitute an important anatomic compartment in
the pathogenesis of HIV infection by providing primaryTRECs are maintained in resting, naive T cells, but be-
cause they are not replicated in the course of cell divi- sites for both virus replication and immunopathology
(Haase, 1999). Compromise of proper lymphoid infra-sion, their levels decline with T cell proliferation. In hu-
mans, TREC levels decrease with age and following HIV structure needed for peripheral expansion of T cells has
been proposed to be an important contributor to theinfection (Douek et al., 1998). In both circumstances,
decreased levels of TRECs could derive from decreased ultimate failure of homeostatic mechanisms acting to
maintain lymphocyte population sizes (Haase, 1999). Tothymic production of naive cells, or increased prolifera-
tive drain on the pool of naive T cells, or both (Hazenberg study the impact of SIV infection on lymphoid tissue
structure and function in SMs, LN biopsies were per-et al., 2000).
To test whether SIV infection of SMs affects the popu- formed in 10 SIV-infected and in 8 uninfected SMs. His-
tologic analysis of LN architecture revealed similar LNlation dynamics of the naive T lymphocyte pool, we
adapted the quantitative-competitive PCR assay devel- morphology in SIV-infected and uninfected SMs, with
the only difference consisting of moderate follicular hy-oped to quantify TREC levels in humans for use in SMs
(Sodora et al., 2000). Since our results (Table 2) and perplasia observed in some of the SIV-infected SMs
Immunity
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Figure 4. Levels of Baseline, Spontaneous, and Activation Induced-Apoptosis in CD4 and CD8 T Cells from SIV-Infected and Uninfected
SMs Were Measured Using Annexin V and 7AAD Staining and Flow Cytometric Analysis
(A) The positive staining for Annexin V and 7AAD induced by the proapoptotic agent Campthotecin. (B) The low levels of baseline (time 0)
and spontaneous (after 48 hr without any stimulus) in both SIV-infected and uninfected SMs. (C) The lack of statistically significant differences
between SIV-infected and uninfected SMs in the rates of baseline, spontaneous, and activation-induced (following 48 hr of ConA stimulation)
apoptosis, measured as rates of Annexin V-positive cells, in either CD4 or CD8 T cells.
(Figures 2C and 2D). Comparative immunophenotypic aberrant apoptosis is believed to be a major contributor
analysis of LN-derived lymphocytes (LNLs) and PBMCs to the progressive T cell depletion observed in AIDS.
from both SIV-infected and uninfected SMs revealed Susceptibility to apoptosis affects both CD4 and CD8
identical patterns, with LNs harboring higher levels of T cell populations and is correlated with the overall level
CD4 T cells, CD4CD69 T cells, and CD8CD28 T of the host immune activation. To investigate whether
cells, and lower levels of CD8CD38 and CD8DR T SIV infection of SMs results in increased levels of lym-
cells, as well as CD4 T cells with lower expression of phocyte apoptosis, we studied the expression of the
CD95 than are seen in the peripheral circulation (Table apoptosis-related markers CD95, CD95L (Fas ligand),
2). These findings are consistent with normal patterns and 7A6 (a 38 kDa protein detected by the Apo 2.7
of lymphocyte distribution seen in healthy humans and mAb that is expressed during early stages of apoptosis)
indicate that CD4 and CD8 T cell compartments are (Koester et al., 1997) in PBMCs and LNLs. No significant
preserved despite longstanding SIV infection in the LNs increases were observed in the levels of expression of
of SMs. Furthermore, the quiescent LN morphology ob- CD95 and CD95L, or in levels of Apo2.7-reactive CD4
served in SIV-infected SMs despite high-level viral repli- or CD8 peripheral blood T cells from SIV-infected as
cation is consistent with an attenuated host immune compared to uninfected SMs (Table 2). Similarly, expres-
response to the infection. sion of CD95, CD95L, or 7A6 was not increased in either
CD4 or CD8 LNLs obtained from SIV-infected SMs.
In situ analysis using the TUNEL assay disclosed simi-SIV Infection of SMs Does Not Result in Increased
larly low levels of lymphocyte apoptosis in the LNs ofLymphocyte Apoptosis
SIV-infected and uninfected SMs (Figures 2E and 2F).An exaggerated sensitivity of uninfected lymphocytes
We also measured the level of spontaneous and activa-to apoptosis is manifest in pathogenic HIV and SIV infec-
tion-induced apoptosis in ex vivo cultures of PBMCstions (Meyaard et al., 1992; Finkel et al., 1995; Gougeon
obtained from SIV-infected and uninfected SMs. The fre-et al., 1996; Haase, 1999). As increased levels of lympho-
quency of apoptotic CD4 and CD8 T cells was deter-cyte apoptosis can contribute to both accelerated loss
of CD4 T cells and impaired lymphocyte regeneration, mined by enumeration of cells reactive with Annexin V
Nonpathogenic SIV Infection of Sooty Mangabeys
447
Figure 5. Expression of the Ki67 Proliferation
Marker in PB-, LN-, and BM-Derived CD4 T
Cells from SIV-Infected (SIV) and Uninfected
(SIV–) SMs
Percentage of proliferating cells are shown
with each bar representing an individual ani-
mal. The analysis was completed for the fol-
lowing numbers of animals: SIV-infected (29 for
PB; 10 for LN and BM); SIV-uninfected (18 for
PB, 8 for LN and BM).
and/or 7-AAD in freshly isolated PBMCs and in PBMCs no differences were observed between infected and un-
infected animals in the level of CD8 T cell proliferationfollowing a 48 hr incubation with either no stimulus or
with ConA stimulation (Figure 4). No differences were (Table 2). Interestingly, high levels of Ki67 CD4 and
CD8 T cells were found in the BM of uninfected SMs,observed between SIV-infected and uninfected SMs in
the levels of baseline, spontaneous, or activation-induced suggesting that the BM may be an important, but pre-
viously unappreciated, site for proliferation of mature Tlymphocyte apoptosis in either CD4 or CD8 T cells.
cells (Table 2; Figure 5). In SIV-infected animals, the
level of Ki67 expression of BM-derived CD4 T cells
Increased Proliferation of CD4 T Cells in SIV-Infected
was significantly higher than in uninfected animals (p 
SMs Is Seen in PB and BM but Not in LNs
0.05). Consistent with the observed quiescent appear-
Measurement of the frequency of CD4 and CD8 T
ance of LN morphology, levels of CD4 or CD8 T cell
cells that express the nuclear marker Ki67 provides a
proliferation, as assessed by Ki67 expression, were not
simple method to assess the rate of proliferating cells
increased in the LN in SIV-infected as compared to unin-
in vivo and correlates well with the results of direct
fected SMs (Table 2; Figure 5).
measurements using BrdU and 2H-glucose labeling
(Mohri et al., 2001; Pitcher et al., 2002). Higher levels of
Ki67 CD4 T cells have been reported in the LNs and Decreased CD4 T Cell Levels in SIV-Infected
SMs Are Associated with Increased LevelsPB of HIV-infected individuals with higher CD4 T cell
count (i.e., 500/cmm), compared to uninfected per- of Immune Activation
We observed significant differences between individualsons (Sachsenberg et al., 1998; Haase, 1999; Orendi
et al., 1998; Hazenberg et al., 2000). In humans with SIV-infected SMs with respect to CD4 T cell counts,
expression of activation markers on CD8 T cells, andadvanced HIV disease, Ki67 expression in CD4 T cells
has been reported to be reduced, suggesting possible the degree of preservation of the naive T cell compart-
ment. These differences suggest that the extent of host-failure of compensatory CD4 T cell proliferation (Fleury
et al., 1998). Importantly, the levels of CD8 T cell, NK virus accommodation may differ between individual SIV-
infected SMs. As such differences may provide cluescell, and B cell proliferation are also increased in HIV and
SIV infections, with the rates of CD8 T cell proliferation concerning the nature of salient determinants of T lym-
phocyte population homeostasis, we sought to delin-being even higher than that of CD4 T cells (Fleury et
al., 1998; Mohri et al., 2001). The fact that CD8 T cells eate immunological correlates of CD4 T cell levels in
the SIV-infected SMs. The relationships between differ-are not targets of HIV or SIV infection argues against
the suggestion that their increased turnover represents ent immunological parameters were assessed using a
series of linear correlation analyses. In SIV-infecteda homeostatic compensatory mechanism and supports
the proposal that increased levels of overall T lympho- SMs, CD4 T cell counts were found to directly correlate
to the percentage of naive CD4 T cells, the number ofcyte proliferation may primarily reflect the chronic state
of immune activation (Hazenberg et al., 2000; Grossman naive CD8 T cells, and the number of CD8CD28 cells
(all with p  0.01, data not shown). A significant inverseet al., 2002).
To evaluate rates of T cell proliferation in SIV-infected correlation was observed between CD4 T cell counts
and the percentage of CD8DR T cells (Figure 6A, p and uninfected SMs, we measured the Ki67 expression
in CD4 and CD8 T cells from PB, LNs, and BM (Table 0.01). Lower CD4 T cell counts were also observed in
association with elevated CD95 expression on CD4 T2; Figure 5). A modest but statistically significant 2-fold
increase was observed in the number of proliferating cells (Figure 6B, p  0.01). Since increased levels of
both activated CD8 T cells and expression of CD95 onCD4 T cells in the blood of SIV-infected SMs (p 0.05).
No correlation was found between CD4 T cell counts CD4 T cells were associated with the decreased CD4
T cell counts, we sought a correlation between markersand levels of Ki67 CD4 T cells in the PB (data not
shown). In contrast to pathogenic HIV and SIV infections, of CD8 T cell activation and of the propensity for apo-
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attenuated antiviral cellular immune responses have
also been observed in SIV-infected SMs (Kaur et al.,
2000; G.S. et al., unpublished data). Collectively, these
observations indicate that SIV-infected SMs avoid im-
munodeficiency by mechanisms that are opposite to
those described in HIV-infected long-term non-pro-
gressor (LTNP) humans in whom active cellular immune
responses are associated with control of viral replication
to exceptionally low levels (Cao et al., 1995; Pantaleo
et al., 1995; Rosenberg et al., 1997; Migueles et al., 2002).
Several alternative explanations exist for this seemingly
paradoxical observation. First, SIV might not be cyto-
pathic for SMs CD4 T cells (with a consequent absence
of the direct loss of CD4 T cells that is characteristic
of HIV infection). Second, SIV-infected SMs may not
experience the bystander consequences of a general-
ized state of immune activation that would otherwise
result in both increased apoptotic loss of uninfected T
lymphocytes and suppression of compensatory T cell
production (with attendant diminished levels of indirect
damage). Third, SMs may be better able to replace T
cells lost to the direct or indirect consequences of the
virus infection than are HIV-infected humans or SIV-
infected RMs (with preserved or potentially even en-
hanced host compensatory responses to CD4 T cell
depletion, accomplished either through increasing the
thymic output of naive cells or the proliferation of mature
CD4 T cells).
In this work and in a series of related studies, we have
sought to distinguish between these possibilities. To
address whether SIV infection is cytopathic for SM CD4
T cells in vivo, we have measured turnover of virus and
virus-infected cells employing the identical methods
that have been used in HIV-infected patients and SIV-
infected RMs (Ho et al., 1995; Wei et al., 1995; Nowak
Figure 6. Decreased CD4 T Cell Counts in SIV-Infected SMs Are et al., 1997). These studies indicate that the high-level
Correlated with Increased Levels of T Cell Activation plasma viremia in SIV-infected SMs is maintained by
Inverse correlations between CD4 T cell counts and frequencies multiple rounds of de novo infection of CD4 T cells
of CD8DR T cells ([A], 19 animals), CD4 T cell counts and CD95 whose longevity is estimated to be as short as the in-
expression (MFI) on CD4 T cells ([B], 13 animals), and a direct fected CD4 T cells present in pathogenic SIV and HIV
correlation between CD95 expression (MFI) on CD4 T cells and infections (R.M. Grant and M.B.F., unpublished data).TNF- production by CD8 T cells ([C], 13 animals) is seen in SIV-
Thus, direct, virus-induced damage alone is likely notinfected SMs. Best-fit lines are shown.
sufficient to cause lymphocyte depletion in pathogenic
SIV or HIV infections.
To explore the possibility that the lack of immunodefi-ptosis of CD4 T cells. A highly significant direct corre-
ciency in naturally SIV-infected SMs is related to thelation was found between the level of PMA/A23187-
absence of immunopathology and preserved lymphoidinduced TNF- production by CD8 T cells and the
regenerative capacity, we performed an extensiveexpression of CD95 on CD4 T cells (Figure 6C, p 
cross-sectional study of the immunological features in0.001). Overall, these analyses indicate that better pres-
a group of infected and uninfected animals. Consistentervation of CD4 T cell counts within SIV-infected SMs
with their lack of clinically relevant immunodeficiency,is associated with preservation of the naive T cell com-
SIV-infected SMs were found to maintain near normalpartment, low levels of CD8 T cell activation, and a
CD4 T cell counts in both PB and lymphoid tissues
lower propensity for apoptosis of CD4 T cells.
despite years of infection. This is in marked contrast
to the generalized depletion of CD4 T cells and the
Discussion progressive disruption of the normal LN structure and
function that accrue during HIV infection of humans and
A very intriguing feature of SIV infection in natural host SIV infection of RMs (Haase, 1999).
species, such as SMs and African green monkeys, is The failure of lymphoid regenerative capacity has
that CD4 T cell depletion and AIDS do not arise despite been proposed as an important factor in the pathogene-
levels of viremia that are as high or higher than those sis of AIDS (McCune, 2001), with BM suppression, re-
observed in HIV-infected humans and SIV-infected RMs duced thymic output, and loss of naive T cells commonly
(this study; Rey-Cuille et al., 1998; Chakrabarti et al., observed in HIV-infected individuals (Ullum et al., 1997;
Douek et al., 1998; Moses et al. 1998; Zhang et al., 1999).2000; Broussard, et al., 2001). In this and other studies,
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The depletion of naive T cells during HIV infection is eration, the percentage of CD4 T cells expressing the
Ki67 proliferation marker was increased in the PB andconsistent with a progressive exhaustion of the regener-
ative capacity of the immune system, as well as a drain BM (but not in the LNs) of the SIV- infected SMs, whereas
no significant differences were observed in the CD8 Ton the naive T cell compartment due to the chronic state
of generalized immune activation. Ultimately, the loss cell compartment. The lack of increased CD8 T cell
proliferation in SIV-infected SMs is consistent with theof naive cells exacerbates the HIV-induced immunodefi-
ciency by limiting the potential of the host to generate attenuated CD8-mediated anti-SIV immune responses
observed in other studies on SMs (see below). The find-primary immune responses against pathogens. Our re-
sults show that the regenerative capacity of the CD4 ing of increased CD4 T cell proliferation in the PB and
BM of SIV-infected SMs may reflect either a compensa-T cell compartment is maintained in SIV-infected SMs.
In SIV-infected SMs, BM morphology and function are tory CD4 T cell regeneration or the presence of CD4 T
cells that are responding to SIV as an antigen. Increasedwell preserved. Thymic function also appears to be pre-
served in SIV-infected SMs, who possess levels of rates of CD4 T cell proliferation were not observed in
the lymphocyte population extant in the LNs, the primaryTRECs in CD4 cells similar to those observed in age-
matched uninfected animals. This result is in contrast anatomic sites where immune responses to systemic
antigens are generated, suggesting that homeostaticto what has been described in the pathogenic SIV infec-
tion of RMs (Sodora et al., 2002) and indicates that mechanisms are primarily responsible for the increased
rates of CD4 T cell proliferation observed in SIV-thymic function is neither impaired nor augmented in
SIV-infected SMs. Further, these results show that nor- infected SMs. However, the fact that SMs are known
to produce anti-SIV antibodies following SIV infectionmal levels of TRECs can be maintained within the CD4
T cell pool of SIV-infected SMs, even in the presence indicates that they do mount anti-SIV CD4 T helper
responses (Fultz et al., 1990). As such, the observedof mildly increased rates of CD4 T cell proliferation, as
long as the size of the naive T cell pool is preserved. increase in CD4 T cell proliferation may alternatively
reflect an SIV antigen-specific T cell response. If so, itThis conclusion is consistent with the observation that
the majority of proliferating CD4 T cells in SIV-infected will be important to determine the true magnitude of
CD4 T cell death that results from the direct cytopathicSMs are of memory/activated phenotype (data not
shown). In all, these results indicate the regenerative effect of SIV infection, and the physiologic impact of
this process above and beyond that arising from normalcapacity of the lymphocyte compartment is not compro-
mised in SIV-infected SMs. T cell activation and proliferation.
SIV-infected SMs were found to exhibit substantialDuring HIV infection, a heightened level of immune
activation is commonly manifest and is associated with interindividual variation in their CD4 T cell counts. Pres-
ervation of higher CD4 levels was found to correlatean expansion of CD8CD38 and CD8DR T cells, the
magnitude of which predicts rates of progression to directly with the degree of conservation of both CD4
and CD8 naive cells, and inversely with the levels ofAIDS (Giorgi et al., 1999; Sousa et al., 2002). Increased
levels of CD8 T cells expressing these activation mark- activated CD8 cells and the expression of CD95 on
CD4 T cells. Thus, even in natural host species, in-ers were also observed in SIV-infected as compared to
uninfected SMs. However, in contrast with HIV-infected creased immune activation can impact the integrity and
turnover of T cell populations, but not to the extent thathumans, the increased levels of CD8CD38 and
CD8DR cells present in SIV-infected SMs are not as- immune function is compromised.
Much attention has focused on the direct cytopathicsociated with decreased levels of CD8CD28 cells and
naive CD8 T cells. consequences of HIV infection for CD4 T cells as the
primary force driving T cell depletion in AIDS. However,Aberrant immune activation seen following HIV infec-
tion may result in both increased rates of T cell destruc- alternative models have also been presented that posit
that the indirect consequences of a maladaptive hosttion and impaired immune system regenerative capacity
(Grossman et al., 2002). The substantially increased sus- immune response to HIV infection, rather than direct
cytopathic consequences of the virus, are primarily re-ceptibility of uninfected CD4 and CD8 T cells to undergo
apoptosis is more highly correlated with the overall level sponsible for the pathogenesis of AIDS (Zinkernagel and
Hengartner, 1994). In this model, immunopathology isof immune activation than with levels of ongoing HIV
replication (Muro-Cacho et al., 1995) and is associated believed to arise as an unintentional consequence of
antiviral CTLs and the proinflammatory cytokines theywith high-level expression of proapoptotic factors such
as CD95, CD95L, TNF, and IFN (Mitra et al., 1996; produce in response to a chronic infection that the im-
mune system is unable to clear. Given that the geneticSloand et al., 1996; Badley et al., 2000). We did not find
any significant evidence of aberrant generalized immune plasticity of HIV may facilitate escape from host immune
responses, the fact that HIV has active mechanisms toactivation or excessive apoptosis (measured either in
vivo or ex vivo) in SIV-infected SMs. The absence of evade CTL clearance, and the ability of the virus to
infect and kill antiviral CD4 T helper cells essential forgeneralized immune activation and bystander immuno-
pathology is likely of fundamental importance in ex- preservation of CD8 T cell function, it is perhaps not
surprising that most HIV-infected persons fail to effec-plaining how natural host species avoid immunodefi-
ciency following SIV infection. tively control virus replication despite the presence of
active antiviral CD8 T cell responses (Walker andThe preservation of near normal numbers of CD4 T
cells in a context of high viremia and short life span of Korber, 2001; Douek et al., 2002). Further, as HIV-spe-
cific CD8 T cells may be impaired in their ability toinfected cells suggests that CD4 T cells should prolifer-
ate at higher rates in order to compensate for the loss proliferate and to lyse infected targets but still able to
produce proinflammatory cytokines (Appay et al., 2000;mediated by SIV. In agreement with this a priori consid-
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nal serologic surveys, the majority of infected SMs studied areMigueles et al., 2002), certain HIV-specific immune re-
known to have acquired their SIV infection by 3 to 4 years of age.sponses may actually be better able to mediate immuno-
For analysis of parameters that may be affected by age, includingpathology than to control virus infection.
recent thymic emigrants and others, age-matched animals were
In summary, our findings indicate that SIV-infected used.
SMs manifest far less of the aberrant generalized im-
mune activation and attendant predisposition to by- Determination of Plasma Viral RNA
Plasma viral RNA levels were quantitated using real-time PCR asstander lymphocyte apoptosis than are seen in patho-
described (Kaur et al., 2001). SIV RNA copy number is determinedgenic CD4 T cell-tropic lentivirus infections. While the
by comparison to an external standard curve consisting of virion-precise mechanisms by which SMs avoid the indirect
derived SIVmac239 RNA previously quantified by the SIV bDNA
consequences of SIV remain to be elucidated, it is nota- method (P. Dailey, personal communication).
ble that SMs fail to mount an active proinflammatory
cellular immune response following SIV infection, and Hematological Studies and Cell Separation
WBC, platelet, and total lymphocyte counts were measured usinglimited SIV-specific CD8 cellular immune responses
standard methods. PBMCs were isolated by density gradient centrif-are found in SMs with established SIV infections (this
ugation. LNLs were isolated from biopsied LNs. BMMCs were iso-work; Kaur et al., 2000). Experimental infection of SMs
lated from BM aspirates via density gradient centrifugation.with uncloned SIVsmm results in overall levels of im-
mune activation (especially in the CD8 T cell popula- Flow Cytometry for Cell Surface Markers
tion) during primary infection that are considerably lower Staining was performed with the following monoclonal antibodies
than those observed when RMs are infected with the (all shown, in preliminary studies, to crossreact with SM cells):
CD20, CD25, CD45RA, CD69, and HLA-DR (FITC); CD2,identical virus inoculum, despite similarly high levels of
CD62L, CD95 (PE); CD4 and CD8 (PE and PerCP, all fromvirus replication in both species (G.S. et al., unpublished
Becton Dickinson, San Jose, CA), FITC-labeled -monkey CD3 (Bio-data). That attenuated host cellular immune responses
source Int, Camarillo, CA); CD4 and CD38 FITC (Ortho Diagnostic
to SIV are evident in SMs from the first days of primary System, Raritan, NJ); CD16 and CD28 FITC, CD95L biotin
infection suggests that their innate pathogen recogni- (Coulter, Miami, FL). PE-labeled Apo2.7 MoAb (Coulter) was used
tion processes may fail to recognize SIV as a “danger- to detect the apoptotic cells in vivo. FITC-labeled Ki67MAb was
used to detect actively proliferating cells (Coulter). Samples usedous” pathogen. As a primary event or as a default path-
for Apo2.7 and Ki67 staining were surface stained for CD4 and CD8,way, SMs may mount anti-SIV immune responses
then fixed and permeabilized using the Pharmingen CytoFix/Perm-skewed toward a Th2-like or T regulatory pattern, which
Kit, and stained intracellularly with the proper MAbs and controls.
may not control viral replication effectively but would Flow cytometric acquisition and analysis of samples was performed
also not engender a deleterious proinflammatory state. on at least 10,000 acquired events on a FACScaliber flow cytometer
In the absence of significant indirect immunopathology, driven by the CellQuest software package (Becton Dickinson).
SIV-infected SMs are able to maintain rates of peripheral
Detection of DNA Fragmentation In Situmature CD4 cell proliferation and levels of production
Apoptotic cells were identified within paraffin sections of LNs byof naive lymphocytes via normal BM and thymic path-
TUNEL staining according to manufacturer’s instructions (Boeh-ways sufficient to compensate for increased rates of
ringer Mannheim).
destruction of CD4 T cells arising from the direct cyto-
pathic consequences of virus infection. In contrast, dur- Studies of Lymphocyte Apoptosis In Vitro
ing HIV infection of humans and SIV infection of RMs, The level of spontaneous and activation-induced apoptosis was
determined in freshly isolated PBMCs (baseline), and after a 48 hrthe generation of active but incompletely effective host
incubation either with no stimulus (spontaneous apoptosis) or withantiviral immune responses leads to the establishment
ConA (activation-induced apoptosis). Rates of apoptotic cells wereof a proinflammatory milieu wherein deleterious indirect
determined by multicolor flow cytometry in both CD4 and CD8 T
consequences of the host immune response arise. cells as percentage of cells reactive to Annexin V alone (early apo-
These indirect consequences of the host immune re- ptosis) or annexin V and 7-AAD (late apoptosis) (all reagents from
sponse precipitate accelerated T cell depletion via acti- Becton Dickinson).
vation-induced apoptosis, that in conjunction with in-
Detection of Signal Joint TRECs in Lymphocytescreased rates of CD4 T cell destruction resulting from
PBMCs were separated into CD4 and CD8 T cell populationsthe direct cytopathic consequences of virus infection
using a FACS Vantage cell sorter (Becton Dickinson). Purity of theand impaired T cell regenerative responses underlie the
sorted subpopulations was greater than 95%. The number of sig-
inexorable depletion of CD4 T cells and progression nal joint TRECs in purified lymphocyte subpopulations were quanti-
to AIDS. In the course of the evolution of the natural tated as described in (Sodora et al., 2000, 2002).
host species for SIV infection, natural selection appears
Intracellular Cytokine Stainingto have favored the development of attenuated virus-
Cytokine production by PBMCs was assessed by flow cytometry.specific host immune responses, wherein the direct con-
MAbs against human IL-2, IL-4, IL-10, IFN, and TNF (Pharmingen)sequences of infection may be tolerated as long as the
were shown to be crossreactive with SMs cytokines. PBMCs were
deleterious indirect consequences of host immune re- incubated for 5 hr in medium containing PMA (10 ng/ml), A23187
sponses are not manifest. (200 ng/ml), and either monensin (10 nM) or brefeldin A (5 nM)
(Sigma). Cells were first surface stained with anti-CD4 and CD8
Mabs, fixed and permeabilized using the CytoFix/CytoPerm KitExperimental Procedures
(Pharmingen), and finally stained intracellularly with the proper MAbs
and controlsAnimals
SMs used in this study are housed at the Yerkes National Primate
Center and maintained in accordance with NIH guidelines. In unin- Statistical Analysis
A two tailed, two-sample Student’s T test was used to calculate Pfected animals, negative SIV PCR of plasma and negative HIV-2
serology confirmed the absence of SIV infection. Based on longitudi- values for differences in means between SIV infected and uninfected
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SMs. To evaluate associations between lymphocyte immunopheno- Prevalence of natural infection with simian immunodeficiency virus
and simian T-cell leukemia virus type I in a breeding colony of sootytypic parameters, Pearson’s correlations were calculated. Since age
was negatively correlated with levels of TRECs, we used analysis mangabey monkeys. AIDS 4, 619–625.
of covariance (ANCOVA) to adjust for the age effect. Assumptions Gehri, R., Hahn, S., Rothen, M., Steuerwald, M., Nuesch, R., and
involving ANCOVA were checked and found to be satisfied. Erb, P. (1996). The Fas receptor in HIV infection: expression on
peripheral blood lymphocytes and role in the depletion of T cells.
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